-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OyfC5o/12+RWYNwjUQNlaU8XxFG4qV7tN9gz1tTKM8LhSapok2+PQQxoqOc2Ys9o dxipnNW0V7axV+T8vHWFHg== 0000950137-02-003259.txt : 20020520 0000950137-02-003259.hdr.sgml : 20020520 20020520162105 ACCESSION NUMBER: 0000950137-02-003259 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20020520 ITEM INFORMATION: Other events FILED AS OF DATE: 20020520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PERRIGO CO CENTRAL INDEX KEY: 0000820096 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 382799573 STATE OF INCORPORATION: MI FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19725 FILM NUMBER: 02657798 BUSINESS ADDRESS: STREET 1: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 BUSINESS PHONE: 6166738451 MAIL ADDRESS: STREET 1: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 8-K 1 c69801e8-k.txt CURRENT REPORT SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2002 PERRIGO COMPANY -------------------------------------------------- (Exact name of registrant as specified in charter) MICHIGAN 0-19725 38-2799573 - --------------- ------------ ------------------- (State of other (Commission (I.R.S. Employer Jurisdiction of File Number) Identification Incorporation) Number) 515 Eastern Avenue, Allegan, Michigan 49010 - ------------------------------------------ ------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (616) 673-8451 - -------------- ITEM 5. Other Events The Perrigo Company announced that it has entered into settlement agreements with certain defendants in a civil antitrust lawsuit. The terms of the settlements resulted in aggregate payments, net of attorney fees and expenses, to the Company of $20.1 million on May 17, 2002, for claims against these defendants. In the fourth quarter of fiscal 2002, the Company will recognize a pre-tax gain of $20.1 million. The effect on net income and earnings per share will be approximately $12.9 million and $.17, respectively. The payments will be included in unusual litigation in the consolidated statement of income. The case is proceeding to trial and discovery is ongoing with the few remaining defendants. The Company can make no prediction as to the outcome of the litigation with these defendants. SIGNATURES Pursuant to the requirement of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PERRIGO COMPANY (Registrant) By: /s/Douglas R. Schrank ------------------------------ Dated: May 20, 2002 Douglas R. Schrank Executive Vice President and Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----